FDA warns about clogged oral syringes, feeding tubes with Teva's lansoprazole
This article was originally published in Scrip
Executive Summary
The US FDA alerted prescribers and patients about reports that Teva's proton-pump inhibitor lansoprazole delayed-release orally disintegrating tablets (ODTs) have clogged and blocked oral syringes and feeding tubes, including both gastric and jejunostomy types, when the drug is administered as a suspension through these devices.